Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Galectin-1 Impairs the Generation of Anti-Parasitic Th1 Cell Responses in the Liver during Experimental Visceral Leishmaniasis.

Bunn PT, Montes de Oca M, Rivera FL, Kumar R, Edwards CL, Faleiro RJ, Ng SS, Sheel M, Wang Y, Amante FH, Haque A, Engwerda CR.

Front Immunol. 2017 Oct 12;8:1307. doi: 10.3389/fimmu.2017.01307. eCollection 2017.

2.

Visceral leishmaniasis after orthotopic liver transplantation: a rare cause of infection.

Pereira CM, Oliveira HM, Lopes V, Gandara J, Ferreira S, Daniel J, Miranda HP.

Transpl Infect Dis. 2016 Apr;18(2):251-4. doi: 10.1111/tid.12511. Epub 2016 Mar 29.

PMID:
26895697
3.

Hepatic stellate cells regulate liver immunity to visceral leishmaniasis through P110δ-dependent induction and expansion of regulatory T cells in mice.

Khadem F, Gao X, Mou Z, Jia P, Movassagh H, Onyilagha C, Gounni AS, Wright MC, Uzonna JE.

Hepatology. 2016 Feb;63(2):620-32. doi: 10.1002/hep.28130. Epub 2015 Oct 10.

PMID:
26289140
4.

[Diarrhea due to visceral leishmaniasis in a liver transplant recipient].

Vargas Acosta AM, Belchí Segura E, Martinez Caselles A, Baños Madrid R, Pons Miñano JA, Parrilla Paricio P.

Gastroenterol Hepatol. 2013 Apr;36(4):271-3. doi: 10.1016/j.gastrohep.2012.12.001. Epub 2013 Feb 28. Spanish. No abstract available.

PMID:
23453560
5.

Canine visceral leishmaniasis: relationships between oxidative stress, liver and kidney variables, trace elements, and clinical status.

Heidarpour M, Soltani S, Mohri M, Khoshnegah J.

Parasitol Res. 2012 Oct;111(4):1491-6. Epub 2012 Jun 6.

PMID:
22669694
6.

Acute liver failure: a rare clinical presentation of visceral leishmaniasis.

Sagnelli C, Di Martino F, Coppola N, Crisci A, Sagnelli E.

New Microbiol. 2012 Jan;35(1):93-5. Epub 2012 Jan 10.

7.

[Two cases of visceral leishmaniasis diagnosed by liver biopsy].

Liu ZZ, Lv XJ.

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2011 Oct;29(5):347. Chinese. No abstract available.

PMID:
24830195
8.

Visceral leishmaniasis in liver transplant recipients from an endemic area.

Clemente WT, Faria LC, Romanelli RM, Lima SS, Cortes JR, Oliveira AP, Carvalho AL, Ferreira AR, Lima AS.

Transplantation. 2011 Apr 15;91(7):806-8. doi: 10.1097/TP.0b013e31820c4574. No abstract available.

PMID:
21436655
9.

Visceral leishmaniasis affects liver and spleen concentrations of amphotericin B following administration to mice.

Gershkovich P, Wasan EK, Sivak O, Li R, Zhu X, Werbovetz KA, Tidwell RR, Clement JG, Thornton SJ, Wasan KM.

J Antimicrob Chemother. 2010 Mar;65(3):535-7. doi: 10.1093/jac/dkp465. Epub 2009 Dec 21.

PMID:
20026611
10.

Progressive visceral leishmaniasis misdiagnosed as cirrhosis of the liver: a case report.

Giannitrapani L, Soresi M, La Spada E, Tripodo C, Montalto G.

J Med Case Rep. 2009 Jun 25;3:7265. doi: 10.4076/1752-1947-3-7265.

11.

Visceral leishmaniasis simulating chronic liver disease: successful treatment with miltefosine.

Avasthi R, Chaudhary SC, Khanna S.

Indian J Med Microbiol. 2009 Jan-Mar;27(1):85-6. No abstract available.

12.

Visceral leishmaniasis among liver transplant recipients: an overview.

Campos-Varela I, Len O, Castells L, Tallada N, Ribera E, Dopazo C, Vargas V, Gavaldà J, Charco R.

Liver Transpl. 2008 Dec;14(12):1816-9. doi: 10.1002/lt.21538. Review. No abstract available.

13.

Human visceral leishmaniasis expresses Th1 pattern in situ liver lesions.

Seixas Duarte MI, Tuon FF, Pagliari C, Kauffman MR, Brasil RA.

J Infect. 2008 Oct;57(4):332-7. doi: 10.1016/j.jinf.2008.07.005. Epub 2008 Aug 21.

PMID:
18722018
14.

High prevalence of functional liver derangement in visceral leishmaniasis at an Indian tertiary care center.

Mathur P, Samantaray JC, Samanta P.

Clin Gastroenterol Hepatol. 2008 Oct;6(10):1170-2. doi: 10.1016/j.cgh.2008.04.033. Epub 2008 Jul 10.

PMID:
18619918
15.

Visceral leishmaniasis: acute liver failure in an immunocompetent Asian-Indian adult.

Malatesha G, Singh NK, Gulati V.

Indian J Gastroenterol. 2007 Sep-Oct;26(5):245-6.

PMID:
18227579
16.

[Liver injury in visceral leishmaniasis in children: systematic review].

Medeiros FS, Tavares-Neto J, D'Oliveira A Jr, Paraná R.

Acta Gastroenterol Latinoam. 2007 Sep;37(3):150-7. Review. Spanish.

PMID:
17955725
17.

Liver transplant recipient with concomitant cutaneous and visceral leishmaniasis.

Ozcan D, Seçkin D, Allahverdiyev AM, Weina PJ, Aydin H, Ozçay F, Haberal M.

Pediatr Transplant. 2007 Mar;11(2):228-32.

PMID:
17300508
18.

An atypical course of visceral leishmaniasis (Kala-azar) in a liver transplant recipient.

Clemente WT, Couto CA, Ribeiro DD, de Medeiros Chaves França M, Sanches MD.

Transplantation. 2007 Feb 15;83(3):368-9. No abstract available.

PMID:
17297421
19.

Visceral leishmaniasis masquerading as chronic liver disease.

Prakash A, Singh NP, Sridhara G, Malhotra V, Makhija A, Garg D, Pathania A, Agarwal SK.

J Assoc Physicians India. 2006 Nov;54:893-4.

PMID:
17249262
20.

[Liver involvement during visceral leishmaniasis].

Gangneux JP, Donaghy L, Marty P.

Gastroenterol Clin Biol. 2006 Aug-Sep;30(8-9):1027-32. Review. French.

Supplemental Content

Loading ...
Support Center